Skip to content

Determination of optimal cutoff value of tongue body color among chronic fatigue patients: A cross-sectional study

Determination of optimal cutoff value of tongue body color among chronic fatigue patients: A cross-sectional study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0004979
Enrollment
60
Registered
2020-04-29
Start date
2019-12-13
Completion date
Unknown
Last updated
2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Sangji University Oriental Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Adults over 19 years 2) Those who satisfy the following three conditions of 'Modified 1994 research case definition criteria for chronic fatigue syndrome worksheet' ? Clinically evaluated, unexplained, persistent or relapsing chronic fatigue that is of new or definite onset ? The concurrent occurrence of four or more of the following symptoms, all of which must have persisted or recurred during 6 or more consecutive months of illness and must not have predated the fatigue ? Exclusion of other clinical causes that may explain fatigue in health screening after the onset

Exclusion criteria

Exclusion criteria: (1) Those who can not open their mouths due to jaw joint disorders (2) Glossities, Anatomical abnormality on the tongue, or intraoral bleeding disorders (3) Orthodontic prostheses in the mouth (4) Smokers (5) Sleep apnea or narcolepsy (6) New drugs within one month (7) currently taking drugs cause fatigue or drowsiness (8) History of malignant tumors, chronic hepatitis, or liver cirrhosis (9) History of major depressive disorder, bipolar affective disorders, schizophrenia, dementia, anorexia nervosa, bulimia (10) History of chronic renal failure, tuberculosis, asthma, or multiple sclerosis (11) History of alcohol or other substance abuse from 2 years before the onset of fatigue into the time of screening (12) Myocardial infarction, Unstable angina pectoris, Stroke, Cerebral ischemic attack, heart failure, uncontrolled arrhythmia, and previous coronary revascularization (13) Severe metabolic disease / Cardiovascular, cerebrovascular disease / Any other diseases or disorders that may affect physical and mental fatigue/ systemic infectious disease requiring treatment (14) Uncontrolled hypertension (SBP >180mmHg or DBP >110 mmHg) or edema (15) BMI greater that 45 kg/m2 (16) Positive HBsAg, HCB-Ab, HIV test (17) Serum creatinine >UNL X 2 times (18) HbA1c > 9% (19) AST, ALT, or serum bilirubin >UNL X 2.5 times (20) TSH below 0.40 mIU/L or over 4.0 mIU/L (21) Currently receiving treatment to improve fatigue (22) Pregnant, lactating, or fertile women, or positive urine pregnancy test results (23) Participants in any other clinical studies within one month of screening (24) Anyone who is deemed unsuitable for other clinically significant medical or psychiatric findings

Design outcomes

Primary

MeasureTime frame
Matching rate among classification categories according to the cut off point and expert judgement results

Secondary

MeasureTime frame
Adverse event rate

Countries

Korea, Republic of

Contacts

Public ContactUi Min Jerng

Sangji University Oriental Medical Center

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026